Month: January 2008

Sonata Software has announced that TUI InfoTec GmbH, Germany, a joint venture between Sonata Software, India and TUI AG, Germany has gained a new client (i.e. LYCOS Europe) outside of TUI group. From February 2008 LYCOS Europe, one of the continent’s leading providers of Internet portals and online advertising, will be using TUI InfoTec as its outsourcing partner for its office IT operations. Migration of the existing set-up to an MPLS network is due to begin this month.

As part of another contract TUI InfoTec has already been looking after LYCOS Europe local area and international WAN networks since 01 December 2007. TUI InfoTec successfully beat off several competitors in the selection process.

Anil Ambani has finally made it public about his IT Consulting ambitions. Fueled with synergies from RCom + Yipes, Anil Ambani has hand picked a team of 15 professionals to scale the IT business.

The company will operate in the domains of consultancy, infrastructure management, application development, management and domestic SME market.

With falling dollar and margins under heavy pressure, Sr executives at Infosys, TCS and Satyam are already looking towards Anil Ambani’s Tech Reliance to make their last Stock Options bounty. Hyderabad, Kolkata, Mumbai and Gurgaon IT centers will open for business within the next 6 weeks.

Venus Remedies has been accredited with the European GMP certification for its cephalosporin and carbapenem plants at Baddi, India, a rare and most coveted certification for regulated markets.
The cephalosporin and carbapenem plants of the company were inspected by the European authorities and found to be complying with the manufacturing and quality control standards as per the European good manufacturing practice.

The European – GMP certification is a pre-requisite for Export to European union. Venus is the only company in India to have an EU-GMP certified plant for carbapenems, which the have huge market potential across the globe. With this accreditation, the company can now freely export to not only 36 countries of European union, but also to Canada and Australia, which recognize European GMP. Now the company can surge ahead in the regulated European and Canadian markets, as per its strategy, in sync with its subsidiary Venus Pharma GmbH, Germany and realize its export targets as per projections.